These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22503967)

  • 1. Enhanced attenuation of nicotine discrimination in rats by combining nicotine-specific antibodies with a nicotinic receptor antagonist.
    LeSage MG; Shelley D; Pravetoni M; Pentel PR
    Pharmacol Biochem Behav; 2012 Jul; 102(1):157-62. PubMed ID: 22503967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reinforcement enhancing effect of nicotine and its attenuation by nicotinic antagonists in rats.
    Liu X; Palmatier MI; Caggiula AR; Donny EC; Sved AF
    Psychopharmacology (Berl); 2007 Nov; 194(4):463-73. PubMed ID: 17616849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine and bupropion share a similar discriminative stimulus effect.
    Young R; Glennon RA
    Eur J Pharmacol; 2002 May; 443(1-3):113-8. PubMed ID: 12044800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists.
    Batman AM; Munzar P; Beardsley PM
    Psychopharmacology (Berl); 2005 May; 179(2):393-401. PubMed ID: 15565434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive immunization with a nicotine-specific monoclonal antibody decreases brain nicotine levels but does not precipitate withdrawal in nicotine-dependent rats.
    Roiko SA; Harris AC; LeSage MG; Keyler DE; Pentel PR
    Pharmacol Biochem Behav; 2009 Aug; 93(2):105-11. PubMed ID: 19393688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of nicotinic receptor antagonism: nicotine discrimination studies.
    Jutkiewicz EM; Brooks EA; Kynaston AD; Rice KC; Woods JH
    J Pharmacol Exp Ther; 2011 Oct; 339(1):194-202. PubMed ID: 21730011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine.
    Gasior M; Shoaib M; Yasar S; Jaszyna M; Goldberg SR
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1053-73. PubMed ID: 10027843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the competitive nicotinic antagonist erysodine on behavior occasioned or maintained by nicotine: comparison with mecamylamine.
    Mansbach RS; Chambers LK; Rovetti CC
    Psychopharmacology (Berl); 2000 Feb; 148(3):234-42. PubMed ID: 10755736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined active and passive immunization against nicotine: minimizing monoclonal antibody requirements using a target antibody concentration strategy.
    Cornish KE; Harris AC; LeSage MG; Keyler DE; Burroughs D; Earley C; Pentel PR
    Int Immunopharmacol; 2011 Nov; 11(11):1809-15. PubMed ID: 21802529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice.
    Tobey KM; Walentiny DM; Wiley JL; Carroll FI; Damaj MI; Azar MR; Koob GF; George O; Harris LS; Vann RE
    Psychopharmacology (Berl); 2012 Sep; 223(2):159-68. PubMed ID: 22526534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic characterization of a nicotine-discriminative stimulus in rhesus monkeys.
    Cunningham CS; Javors MA; McMahon LR
    J Pharmacol Exp Ther; 2012 Jun; 341(3):840-9. PubMed ID: 22438471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine's enhancing effects on responding maintained by conditioned reinforcers are reduced by pretreatment with mecamylamine, but not hexamethonium, in rats.
    Jones J; Raiff BR; Dallery J
    Exp Clin Psychopharmacol; 2010 Aug; 18(4):350-8. PubMed ID: 20695691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of nicotine's ability to serve as a negative feature in a Pavlovian appetitive conditioning task in rats.
    Bevins RA; Wilkinson JL; Palmatier MI; Siebert HL; Wiltgen SM
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):470-81. PubMed ID: 16047193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the nicotinic acetylcholine receptor antagonist mecamylamine on the discriminative stimulus effects of cocaine in male rhesus monkeys.
    Banks ML
    Exp Clin Psychopharmacol; 2014 Jun; 22(3):266-73. PubMed ID: 24548245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats.
    Yuan M; Malagon AM; Yasuda D; Belluzzi JD; Leslie FM; Zaveri NT
    Behav Brain Res; 2017 Aug; 333():251-257. PubMed ID: 28693859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine and methamphetamine share discriminative stimulus effects.
    Gatch MB; Flores E; Forster MJ
    Drug Alcohol Depend; 2008 Jan; 93(1-2):63-71. PubMed ID: 17961933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of dextromethorphan and dextrorphan on nicotine discrimination in rats.
    Wright MJ; Vann RE; Gamage TF; Damaj MI; Wiley JL
    Pharmacol Biochem Behav; 2006 Nov; 85(3):507-13. PubMed ID: 17112574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.
    LeSage MG; Shelley D; Ross JT; Carroll FI; Corrigall WA
    Pharmacol Biochem Behav; 2009 Jan; 91(3):461-7. PubMed ID: 18817808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus properties of the nicotinic agonist cytisine.
    Chandler CJ; Stolerman IP
    Psychopharmacology (Berl); 1997 Feb; 129(3):257-64. PubMed ID: 9084064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.